## **TRUSTEES’ ANNUAL REPORT** 

## **Insulinoma Charity UK** 

For the period 6 April 2025 to 5 April 2026 **Registered charity number 1204926** 

Supporting people affected by insulinoma and their families, and advancing public and professional understanding of this rare condition. 

> **LEGAL FORM** Charitable incorporated organisation (foundation model) 

> **REGISTERED OFFICE** 96 Empress Avenue, West Mersea, Colchester, Essex CO5 8BL 

> **WEBSITE** www.insulinomacharityuk.org 



**TRUSTEES’ ANNUAL REPORT  ·  YEAR ENDED 5 APRIL 2026** 

## **1. Reference and administrative details** 

The trustees present their annual report for Insulinoma Charity UK for the period from 6 April 2025 to 5 April 2026. It accompanies the charity’s receipts and payments accounts for the same period. 

|026. It accompanies the charity’s|receipts and payments accounts for the same period.|
|---|---|
||Insulinoma Charity UK|
|**Registered name**||
||1204926|
|**Charity number**||
||Charitable incorporated organisation (CIO), foundation model|
|**Legal structure**||
||Constitution registered on 26 September 2023|
|**Governing document**||
||96 Empress Avenue, West Mersea, Colchester, Essex CO5 8BL|
|**Registered office**||
||The Co-operative Bank|
|**Banker**||



## **Trustees** 

||||
|---|---|---|
|**Trustee**|**Role**|**Period of service**|
||||
|Enola Patricia Wright|Chair|Whole reporting period; serving at approval|
|Peter David Collins|Treasurer|Whole reporting period; serving at approval|
|Paula Davis|Secretary|Served until 14 February 2026|
|Andrew Derek Davis|Trustee and Secretary|Appointed in February 2026; serving at approval|



## **2. Objectives and public benefit** 

## The charity’s object is: 

_“The relief of persons suffering or at risk of suffering from insulinoma and their families by advancing the education of the public, including medical practitioners, in all aspects of insulinoma by promoting research into its causes and treatment and by disseminating the useful results of such research.”_ 

The trustees have had due regard to the Charity Commission’s guidance on public benefit when planning the charity’s activities. The charity delivers public benefit by making reliable information and peer support more accessible, helping affected people and families feel less isolated, improving awareness of insulinoma, and sharing useful learning about research and treatment. 

Insulinoma Charity UK  |  Registered charity 1204926 

Page 2 



**TRUSTEES’ ANNUAL REPORT  ·  YEAR ENDED 5 APRIL 2026** 

## **3. Activities and achievements** 

Insulinoma Charity UK is entirely volunteer led. During the year, trustees and volunteers concentrated on practical support, trustworthy information, community connection, awareness and fundraising. 

## **Support and community** 

The charity provided one-to-one guidance and peer connection for people at different stages of the insulinoma journey, including those seeking a diagnosis, people living with a confirmed or malignant insulinoma, and families navigating surgery, treatment and recovery. 

By December 2025, the charity’s online communities included more than 1,000 members in its diagnosedinsulinoma group, more than 1,500 in its suspected-insulinoma group, and 102 in its malignant-insulinoma group. 

_These are community membership figures rather than unique beneficiary totals; an individual may belong to more than one group._ 

## **Information, awareness and research** 

- Maintained online information and peer-led resources, grounded in lived experience and designed to help people prepare for clinical conversations. 

- Shared information about relevant research and emerging treatment options, including information about the upLIFT study, without replacing individual medical advice. 

- Continued work to develop psychological support tailored to the needs of people affected by insulinoma and their families. 

- Engaged with clinicians, researchers and the wider community to improve understanding of insulinoma and to bring patient experience into discussions about care. 

## **Fundraising highlights** 

Supporters raised funds and awareness through personal challenges and memorial events. Publicised highlights during the reporting year included: 

||||
|---|---|---|
|**Supporter**|**Activity**|**Publicised**<br>**total**|
||||
|Katie Robertson|London Landmarks Half Marathon, in memory of Graham|£2,325.00|
|Becky Darby and Sharron Lynch|Memorial charity gala for Callum Lynch|£7,100.00|
|Ian Houson|AJ Bell Great Scottish Run|£2,963.67|
|Elliot Wright|Blenheim Palace Triathlon|£1,000.00|



_Campaign totals are shown as publicised. Accounting receipts are reported separately in section 5 and may differ because of timing, donation route or processing arrangements._ 

## **Priorities for 2026–27** 

- Pilot a residential retreat bringing together peer support, practical information and specialist psychological support. 

- Strengthen the quality and reach of information for patients, families and professionals. 

- Develop sustainable fundraising while protecting the charity’s independence and patient-first purpose. 

Insulinoma Charity UK  |  Registered charity 1204926 

Page 3 



**TRUSTEES’ ANNUAL REPORT  ·  YEAR ENDED 5 APRIL 2026** 

## **4. Structure, governance and management** 

## **Constitution and trustee appointment** 

Insulinoma Charity UK is a foundation CIO. Under its constitution, the only voting members are the charity trustees. New trustees are appointed for life by resolution at a properly convened trustee meeting, with regard to the skills, knowledge and experience needed for effective administration. No external person or body is entitled to appoint trustees. 

## **Trustee change during the year** 

Paula Davis, a founding trustee and the charity’s Secretary, died on 14 February 2026 and ceased to hold office on that date. The trustees record their gratitude for her contribution to establishing and supporting the charity. Andrew Derek Davis was appointed by trustee resolution during February 2026 and accepted appointment as Trustee and Secretary. 

## **How the charity is managed** 

The trustees are responsible for strategy, safeguarding the charity’s assets, legal and regulatory compliance, financial oversight and the delivery of charitable activities. Day-to-day work is carried out by trustees and volunteers; the charity had no paid employees during the year. 

Trustees consider conflicts of interest in accordance with the constitution and make collective decisions in the charity’s best interests. New trustees receive the governing document, key policies, current financial information and an explanation of trustee duties and the charity’s activities. 

## **Risk management** 

|||
|---|---|
|**Principal risk**|**How it is managed**|
|||
|Volunteer capacity and continuity|Share responsibilities, document key processes and keep trustee succession and<br>volunteer support under review.|
|Quality and safety of health<br>information|Use reputable sources, distinguish peer experience from medical advice and<br>encourage users to consult qualified clinicians.|
|Safeguarding, privacy and online<br>communities|Apply safeguarding and data-protection policies, moderate communities and<br>restrict access to personal information.|
|Income concentration and<br>independence|Develop a broader supporter base, review significant funding relationships and<br>retain trustee control of content and priorities.|
|Financial control and regulatory<br>compliance|Review expenditure, bank balances, filings and key obligations through trustee<br>oversight.|



## **Trustee remuneration and expenses** 

No trustee received remuneration or other benefit for acting as a trustee. Payments of £586 recorded as trustee travel and accommodation represented reimbursement of costs incurred on charity business. 

Insulinoma Charity UK  |  Registered charity 1204926 

Page 4 



**TRUSTEES’ ANNUAL REPORT  ·  YEAR ENDED 5 APRIL 2026** 

## **5. Financial review** 

The accounts have been prepared on the receipts and payments basis. All funds held during the year were unrestricted. The charity had no restricted funds or endowment funds. 

## **Financial performance** 

||||
|---|---|---|
||**2025–26**|**2024–25**|
||||
|Total receipts|£25,143|£4,112|
|Total payments|£6,427|£1,056|
|Net receipts|£18,716|£3,056|
|Cash at year end|£28,764|£10,048|



Income grew substantially during the year, reflecting corporate donations, private donations and community fundraising support. Expenditure increased as the charity invested in member content, awareness and branding, and the digital and regulatory foundations needed to support its work. 

## **Receipts** 

|||
|---|---|
|**Source**|**Unrestricted funds**|
|||
|Corporate donations|£10,000|
|Private donations|£9,474|
|JustGiving donations|£5,415|
|Insulinoma e-Book proceeds|£0|
|Bank interest|£254|
|**Total receipts**|**£25,143**|



## **Payments** 

|||
|---|---|
|**Expenditure**|**Unrestricted funds**|
|||
|Software and website fees and licences|£863|
|Regulator fees and licences|£60|
|Other fees and licences|£97|
|Trustee travel and accommodation expenses|£586|
|Charity promotion and branding|£2,313|
|Bank charges|£8|
|Purchase of member content|£2,500|
|**Total payments**|**£6,427**|



Insulinoma Charity UK  |  Registered charity 1204926 

Page 5 



**TRUSTEES’ ANNUAL REPORT  ·  YEAR ENDED 5 APRIL 2026** 

## **6. Reserves and financial position** 

## **Reserves policy** 

The trustees’ policy is to retain sufficient unrestricted cash to meet foreseeable operating costs, maintain core support and information services, and meet committed or planned charitable expenditure. Because the charity is at an early stage of development and income can fluctuate, no fixed numerical target was set during the year. The trustees review the level and purpose of reserves at least annually. 

At 5 April 2026, unrestricted cash reserves were £28,764. The trustees consider this level appropriate in light of the charity’s plans to extend support, develop specialist content and psychological support, and protect continuity if income varies. 

## **Assets and liabilities** 

|||
|---|---|
|**Cash funds at 5 April 2026**|**Unrestricted funds**|
|||
|The Co-operative Bank — current account|£438|
|The Co-operative Bank — deposit account|£28,326|
|**Total cash funds**|**£28,764**|



No other monetary assets, investment assets, assets retained for the charity’s own use or liabilities were recorded in the receipts and payments accounts. There were no fund deficits. 

## **Events after the reporting period** 

After the year end, the charity entered into a £25,000 founding partnership with Rezolute. The funding was received in September 2026 and is therefore not included in the 2025–26 receipts and payments accounts. It is intended to support the pilot residential retreat planned for October 2026 and the development of further retreats, while the trustees retain responsibility for the charity’s activities, information and priorities. 

## **Trustees’ responsibilities** 

The trustees are responsible for preparing this report and the charity’s accounts, keeping appropriate accounting records, safeguarding the charity’s assets and taking reasonable steps to prevent and detect fraud and other irregularities. The trustees confirm that this report reflects the charity’s activities and financial position for the period stated. 

## **Approval** 

This report was approved by the trustees and signed on their behalf by an authorised trustee. 

|**Date of approval**|____________________________________|
|---|---|
|**Signature**|____________________________________|
|**Name**|Enola Patricia Wright|
|**Position**|Chair and authorised trustee|



Insulinoma Charity UK  |  Registered charity 1204926 

Page 6 



||**Charity Name**<br> <br>**Insulinoma Charity UK**<br>|**Charity Name**<br> <br>**Insulinoma Charity UK**<br>|**Charity Name**<br> <br>**Insulinoma Charity UK**<br>|**No (if any)**<br>**1204926**|**CC16a**|
|---|---|---|---|---|---|
||**For the period**<br>**from**|06/04/2025<br>Period start date|**To**|Period end date<br>05/04/2026||
|||||||
|**Section A Receipts and payments**||||||
|**A1 Receipts**|**Unrestricted**<br>**funds**<br>**to the nearest      £**<br>**-**<br>**10,000**<br>**9,474**<br>**5,415**<br>**-**<br>**254**<br>**-**<br> **25,143**<br>**-**<br>**-**<br> **-**<br> **25,143**|**Restricted**<br>**funds**<br>**to the nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**Endowment**<br>**funds**<br>**to the nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**Total funds**<br>**to the nearest £**<br>**-**<br>**10,000**<br>**9,474**<br>**5,415**<br>**-**<br>**254**<br>**-**<br>**-**<br>**25,143**<br>**-**<br>**-**<br>**-**<br>**25,143**|**Last year**<br>**to the nearest £**|
|Initial donation|**-**||||**-**|
|Corporate donations|**10,000**||||**-**|
|Private donations|**9,474**||||**3,650**|
|Just Giving donations|**5,415**||||**4,605**|
|Insulinoma e-Book proceeds|**-**||||**4**|
|Interest|**254**||||**73**|
||||||**-**|
|Adjustment:<br>Just Giving funds incorrectly shown as receipt<br>in A1 Receipts in 2024/25 was actually post<br>Year End in 2025|**-**||||**-                     4,220**|
|**_Sub total_**_(Gross income for AR)_|**25,143**||||**4,112**|
|||||||
|**A2 Asset and investment sales,**<br>**(see table).**||||||
||**-**||||**-**|
||**-**||||**-**|
|**_Sub total_**|**-**||||**-**|
|**_Total receipts_ **||||||
||**25,143**|**-**|**-**|**25,143**|**4,112**|



|**A3 Payments**|**-**<br>**863**<br>**60**<br>**97**<br>**586**<br>**2,313**<br>**8**<br>**2,500**<br>**-**<br> **6,427**<br>**-**<br>**-**<br> **-**<br>**6,427**<br>**18,716**<br>**-**<br>**10,048**<br>**28,764**|**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**||**-**<br>**863**<br>**60**<br>**97**<br>**586**<br>**2,313**<br>**8**<br>**2,500**<br>**-**<br>**6,427**<br>**-**<br>**-**<br>**-**<br>**6,427**<br>**18,716**<br>**-**<br>**10,048**<br>**28,764**||
|---|---|---|---|---|---|
|Fund raising event costs/fees|**-**||**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**-**|**900**|
|Software and Website fees/licenses|**863**|||**863**|**156**|
|Regulator fees/licenses|**60**|||**60**|**-**|
|Other fees/licenses|**97**|||**97**|**-**|
|Trustee Exp - travel, accomodation|**586**|||**586**|**-**|
|Charity promotion and branding|**2,313**|||**2,313**|**-**|
|Bank charges|**8**|||**8**|**-**|
|Purchase of member content|**2,500**|||**2,500**|**-**|
|Member event costs/fees|**-**|||**-**|**-**|
|**_Sub total_ **|**6,427**||**-**|**6,427**|**1,056**|
||||**-**<br>**-**<br>**-**|||
|**A4 Asset and investment**<br>**purchases, (see table)**||||||
||**-**|||||
||**-**|||||
|**_Sub total_ **|**-**||||**-**|
|**_Total payments_**<br>**_Net of receipts/(payments)_**<br>**A5 Transfers between funds**<br>**A6 Cash funds last year end**<br>**_Cash funds this year end_**||||||
||||**-**|**6,427**|**1,056**|
|||||||
||**18,716**|**-**|**-**|**18,716**|**3,056**|
||**-**|**-**|**-**<br>**-**|**-**|**-**|
||**10,048**|**-**||**10,048**|**-**|
||**28,764**|**-**|**-**|**28,764**|**3,056**|



## **Section B Statement of assets and liabilities at the end of the period** 

|**Categories**<br>**B1 Cash funds**|Co-operative Bank - Current Account<br>Co-operative Bank - Deposit Account<br>**Details**|**Unrestricted**<br>**funds**<br>**to nearest £**<br>**438**<br>**28,326**<br>**-**|**Restricted**<br>**funds**<br>**to nearest £**<br>**-**<br>**-**<br>**-**|**Endowment**<br>**funds**<br>**to nearest £**|
|---|---|---|---|---|
||Co-operative Bank - Current Account||**-**|**-**|
||Co-operative Bank - Deposit Account||**-**|**-**|
||||**-**|**-**|





|Signed by one or two trustees on behalf of<br>all the trustees<br>**B5 Liabilities**<br>**B4 Assets retained for the**<br>**charity’s own use**<br>**B3 Investment assets**<br>**B2 Other monetary assets**|<br>Signature<br>**Details**<br>**Details**<br>**Details**<br>**Details**<br>**_Total cash funds_**<br>(agree balances with receipts and payments<br>account(s))|**28,764**|**-**|
|---|---|---|---|
||||OK|
|||**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**to nearest £**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**asset belongs**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**asset belongs**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**liability relates**<br>**Amount due**<br>**(optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>Print Name<br>Enola Wright<br>Peter Collins|**Endowment**<br>**funds**<br>**to nearest £**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**When due**<br>**(optional)**|
|||||
|||||
|||||
|||||
|||||
|||||
||||Date of<br>approval|
|||Enola Wright|**14/09/2026**|
|||Peter Collins|**14/09/2026**|





CHARITY COMMISSION, Independent examinerfs
FOR ENGLAND AND WALES;
report on the accounts
Seetlon A
Independent Examlnerfg Report
Report to the trusteesl
members of
Insulinoma Charrty UK
On accounts for the year 0510412026
ended
Charlty no ' 1204926
(if any)
Set out on pages
I report to the trustees on my examination of the accounts of ttE attye
chanty ("the Trust-) for the year ended 05 10412026.
Responslbillties and As the chanty trustees of the Trust. you are responsible for the Pfeparation
basis of report of the accounts in accordance with the requirements of the Charrt*s Act
2011 ("the Act")
I report In respect of my examination of the Trust's accounts carried out
under section 145 of the 2011 Act and In carrying out my examination. I
have followed the applicable Directions given by the Chanty Commission
under section 145(5)(b) of the Act
I have completed my examination. I confirm that no malenal matters have
come to my attention (other than that disclosed below ") In connethon wrth
the examination which gives me cause to believe that In, any rnater￿1
respect."
accounting records were not kept in accordance wrth section 130 of
the Act or
the accounts do not accord wrth the accounting records
I have no concems and have come across no other matters In connecb.on
with the examination to which attention should be drawn In order to enable a
proper understanding of the accounts to be reached.
Please del te Ihe words In the brackets if they do not apply.
07110r2026
Independent
examiner's statsment
Signed:
Date:
Name:
David Peter Collins
Relevant professional
qualification(s) or body
(if any):
Arr (Association of Taxation Technicians) - 10+ years
Address:
Chaucer House, New Thorpe Ave
Thorpe-le-soken, Essex. C016 OLR
IER
October 2018
Section B
Disclosure
Only complete If the examiner needs to highlight matters of concern (see CC32.
Independent examination of chanty accounts directions and guidance for
examiners).
Give here brief detsils of
any items that the
examiner wishes to
dlsclose
None
IER
October 2018